Cytosorbents
CTSO
#10647
Rank
โ‚ฌ19.64 M
Marketcap
0,31ย โ‚ฌ
Share price
-0.33%
Change (1 day)
-69.74%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2026 (TTM): -โ‚ฌ10.51 Million

According to Cytosorbents's latest financial reports the company's current earnings are โ‚ฌ37.2 Million. In 2025 the company made an earning of -โ‚ฌ7.46 Million, an increase over its 2024 earnings that were of -โ‚ฌ19.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ10.51 Million40.96%
2025 -โ‚ฌ7.46 Million-62.16%
2024 -โ‚ฌ19.69 Million-22.49%
2023 -โ‚ฌ25.41 Million-13.52%
2022 -โ‚ฌ29.38 Million34.04%
2021 -โ‚ฌ21.92 Million182.17%
2020 -โ‚ฌ7.77 Million-55.97%
2019 -โ‚ฌ17.64 Million14.17%
2018 -โ‚ฌ15.45 Million95.14%
2017 -โ‚ฌ7.92 Million-22.32%
2016 -โ‚ฌ10.2 Million39.1%
2015 -โ‚ฌ7.33 Million-12.89%
2014 -โ‚ฌ8.41 Million89%
2013 -โ‚ฌ4.45 Million26.65%
2012 -โ‚ฌ3.52 Million-26.02%
2011 -โ‚ฌ4.75 Million-288.45%
2010 โ‚ฌ2.51 M-4.17%
2009 โ‚ฌ2.62 M-287.19%
2008 -โ‚ฌ1.41 Million-47.12%
2007 -โ‚ฌ2.66 Million41.78%
2006 -โ‚ฌ1.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
โ‚ฌ3.24 B-30,646.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
โ‚ฌ0.67 B-6,447.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
โ‚ฌ48.08 M-553.11%๐Ÿ‡บ๐Ÿ‡ธ USA